Medpace News

Medpace Holdings Is Maintained at Buy by Guggenheim

Medpace Holdings Is Maintained at Buy by Guggenheim

Dow JonesApr 24 13:52 ET

Express News | Guggenheim Maintains Buy on Medpace Hldgs, Raises Price Target to $464

Moomoo 24/7Apr 24 13:43 ET

Medpace Holdings, Inc. (NASDAQ:MEDP) Q1 2024 Earnings Call Transcript

Yahoo FinanceApr 24 10:37 ET

Medpace Holdings, Inc. Just Beat EPS By 30%: Here's What Analysts Think Will Happen Next

Yahoo FinanceApr 24 08:09 ET

Medpace Holdings Is Maintained at Outperform by Baird

Medpace Holdings Is Maintained at Outperform by Baird

Dow JonesApr 24 07:00 ET

Express News | Medpace Holdings Inc : Guggenheim Raises Target Price to $464 From $453

Moomoo 24/7Apr 24 06:56 ET

Express News | Baird Maintains Outperform on Medpace Hldgs, Raises Price Target to $454

Moomoo 24/7Apr 24 06:50 ET

Medpace Holdings Inc (MEDP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...

Yahoo FinanceApr 24 03:08 ET

Q1 2024 Medpace Holdings Inc Earnings Call

Yahoo FinanceApr 23 22:35 ET

ENPH, SEDG and MEDP Are Among After Hour Movers

Seeking AlphaApr 23 17:04 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $1.7 million. ABVC BioPharma (NAS

BenzingaApr 23 16:31 ET

Earnings Call Summary | Medpace(MEDP.US) Q1 2024 Earnings Conference

The following is a summary of the Medpace Holdings, Inc. (MEDP) Q1 2024 Earnings Call Transcript:Financial Performance:Medpace reported Q1 2024 revenue of $511 million, up by 17.7% year-over-year.The

moomoo AIApr 23 14:56 ET · Conference Call

Express News | Bruker Shares Are Trading Higher Amid Strength in Life Sciences Tools Stocks Following Strong Earnings From Danaher and Strong Guidance From Medpace

Moomoo 24/7Apr 23 13:37 ET

Decoding 5 Analyst Evaluations For Medpace Hldgs

Throughout the last three months, 5 analysts have evaluated Medpace Hldgs (NASDAQ:MEDP), offering a diverse set of opinions from bullish to bearish.The table below summarizes their recent ratings, sho

BenzingaApr 23 12:01 ET

Express News | Medpace Holdings Shares Are Trading Higher After the Company Issued Strong FY24 Guidance. Jefferies Upgraded the Stock to Buy and Raised Its Price Target to $450

Moomoo 24/7Apr 23 11:11 ET

Express News | Jefferies Upgrades Medpace Hldgs to Buy, Raises Price Target to $450

Moomoo 24/7Apr 23 11:08 ET

Medpace Hldgs Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/23/2024 13.28% Jefferies $340 → $450 Upgrades Hold → Buy 03/18/2024 -0.56% Deutsche Bank → $395 Initiat

BenzingaApr 23 11:06 ET

Global Clinical Trials Market Analysis, Size, and Forecasts 2023 and 2024-2030 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, Sanofi, and Medpace - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been added to Research

BusinesswireApr 23 10:40 ET

Are Strong Financial Prospects The Force That Is Driving The Momentum In Medpace Holdings, Inc.'s NASDAQ:MEDP) Stock?

Medpace Holdings (NASDAQ:MEDP) has had a great run on the share market with its stock up by a significant 27% over the last three months. Given that the market rewards strong financials in the long-

Simply Wall StApr 23 10:11 ET

Express News | Medpace Holdings Inc : Jefferies Raises to Buy From Hold; Raises Target Price to $450 From $340

Moomoo 24/7Apr 23 00:11 ET